BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, Lise M. Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience. Ann Surg Oncol 2003;10:1077-85. [DOI: 10.1245/aso.2003.03.520] [Cited by in Crossref: 136] [Cited by in F6Publishing: 61] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Liu C, Lu P, Lu Y, Xu H, Wang S, Chen J. Clinical implications of metastatic lymph node ratio in gastric cancer. BMC Cancer. 2007;7:200. [PMID: 17958880 DOI: 10.1186/1471-2407-7-200] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
2 Ausborn NL, Wang T, Wentz SC, Washington MK, Merchant NB, Zhao Z, Shyr Y, Chakravarthy AB, Xia F. 53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma. BMC Cancer 2013;13:155. [PMID: 23530749 DOI: 10.1186/1471-2407-13-155] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
3 Zhao RS, Liu YN, Dai WG, Chen SL, Ye JN, Zhai ET, Cai SR, Chen JH. A Substage Increase in The AJCC Classification System Improves Prognostic Prediction in Stage III Gastric Cancer With Insufficient Lymph Nodes Removed. Front Oncol 2021;11:624413. [PMID: 33763360 DOI: 10.3389/fonc.2021.624413] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Deng J, Liang H, Zhang R, Sun D, Pan Y, Zhang L, Hao X. Clinicopathologic characteristics and outcomes of surgery of middle-third gastric cancer. Tumour Biol 2012;33:2091-8. [PMID: 22869239 DOI: 10.1007/s13277-012-0468-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Akagi T, Shiraishi N, Kitano S. Lymph node metastasis of gastric cancer. Cancers (Basel). 2011;3:2141-2159. [PMID: 24212800 DOI: 10.3390/cancers3022141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
6 Bilici A, Seker M, Ustaalioglu BB, Yilmaz B, Doventas A, Salepci T, Gumus M. Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer. Med Oncol. 2010;27:975-984. [PMID: 19885750 DOI: 10.1007/s12032-009-9319-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
7 Zhang YF, Shi J, Yu HP, Feng AN, Fan XS, Lauwers GY, Mashimo H, Gold JS, Chen G, Huang Q. Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus. World J Gastroenterol 2012; 18(27): 3602-3609 [PMID: 22826627 DOI: 10.3748/wjg.v18.i27.3602] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
8 El Hanafy E, El Nakeeb A, Ezzat H, Hamdy E, Atif E, Kandil T, Fouad A, Wahab MA, Monier A. How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience. World J Gastrointest Surg 2016; 8(6): 444-451 [PMID: 27358677 DOI: 10.4240/wjgs.v8.i6.444] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Hou Y, Wang X, Chen J. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer. World J Surg Oncol 2018;16:198. [PMID: 30286762 DOI: 10.1186/s12957-018-1504-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 Jonnalagadda S, Arcinega J, Smith C, Wisnivesky JP. Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer. Cancer 2011;117:4724-31. [PMID: 21452193 DOI: 10.1002/cncr.26093] [Cited by in Crossref: 49] [Cited by in F6Publishing: 65] [Article Influence: 4.9] [Reference Citation Analysis]
11 Jeon SR, Cho JY, Bok GH, Lee TH, Kim HG, Cho WY, Jin SY, Kim YS. Does immunohistochemical staining have a clinical impact in early gastric cancer conducted endoscopic submucosal dissection? World J Gastroenterol 2012; 18(33): 4578-4584 [PMID: 22969232 DOI: 10.3748/wjg.v18.i33.4578] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
12 Qie YY, Xue XF, Wang XG, Dang SC. Application of artificial intelligence in the diagnosis and prediction of gastric cancer. Artif Intell Gastroenterol 2020; 1(1): 12-18 [DOI: 10.35712/aig.v1.i1.12] [Reference Citation Analysis]
13 Liu L, Hao H, Zhao L, Hu J, Si B. Analysis of survival and prognosis of 298 gastric adenocarcinoma patients with no distant metastasis. Oncol Lett 2017;14:7813-6. [PMID: 29344226 DOI: 10.3892/ol.2017.7202] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Arigami T, Natsugoe S, Uenosono Y, Mataki Y, Ehi K, Higashi H, Arima H, Yanagida S, Ishigami S, Hokita S, Aikou T. Evaluation of sentinel node concept in gastric cancer based on lymph node micrometastasis determined by reverse transcription-polymerase chain reaction. Ann Surg 2006;243:341-7. [PMID: 16495698 DOI: 10.1097/01.sla.0000201453.65534.f1] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 5.5] [Reference Citation Analysis]
15 Zhao D, Xu H, Li K, Sun Z. Prognostic factors for patients after curative resection for proximal gastric cancer. J Huazhong Univ Sci Technolog Med Sci 2010;30:530-5. [PMID: 20714884 DOI: 10.1007/s11596-010-0463-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
16 Zhang JW, Chu YM, Lan ZM, Tang XL, Chen YT, Wang CF, Che X. Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma. World J Gastroenterol 2015; 21(14): 4255-4260 [PMID: 25892876 DOI: 10.3748/wjg.v21.i14.4255] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
17 Deng JY, Liang H. Clinical significance of lymph node metastasis in gastric cancer. World J Gastroenterol 2014; 20(14): 3967-3975 [PMID: 24744586 DOI: 10.3748/wjg.v20.i14.3967] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 80] [Article Influence: 11.4] [Reference Citation Analysis]
18 Kavaliauskas P, Maziukas R, Samalavicius NE, Kuliavas J, Lunevicius R. Subtotal gastrectomy with conventional D2 lymphadenectomy for carcinoma of the distal gastric portion: A retrospective cohort study on clinical outcomes. Ann Med Surg (Lond) 2016;6:36-41. [PMID: 27141301 DOI: 10.1016/j.amsu.2016.01.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Kim MK, Warner RR, Ward SC, Harpaz N, Roayaie S, Schwartz ME, Itzkowitz S, Wisnivesky J. Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors. Neuroendocrinology 2015;101:58-65. [PMID: 25572143 DOI: 10.1159/000371807] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
20 Sakcak I, Yıldız BD, Avşar FM, Akturan S, Kilic K, Cosgun E, Hamamci EO. Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer? World J Gastroenterol 2011; 17(35): 4007-4012 [PMID: 22046089 DOI: 10.3748/wjg.v17.i35.4007] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
21 Lee CM, Park SS, Kim JH. Current status and scope of lymph node micrometastasis in gastric cancer. J Gastric Cancer 2015;15:1-9. [PMID: 25861517 DOI: 10.5230/jgc.2015.15.1.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
22 Fukuda N, Sugiyama Y, Midorikawa A, Mushiake H. Prognostic significance of the metastatic lymph node ratio in gastric cancer patients. World J Surg 2009;33:2378-82. [PMID: 19760318 DOI: 10.1007/s00268-009-0205-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
23 Hwang SH, Kim HI, Song JS, Lee MH, Kwon SJ, Kim MG. The Ratio-Based N Staging System Can More Accurately Reflect the Prognosis of T4 Gastric Cancer Patients with D2 Lymphadenectomy Compared with the 7th American Joint Committee on Cancer/Union for International Cancer Control Staging System. J Gastric Cancer 2016;16:207-14. [PMID: 28053806 DOI: 10.5230/jgc.2016.16.4.207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Shin K, Park SJ, Lee J, Park CH, Song KY, Lee HH, Seo HS, Jung YJ, Park JM, Lee SH, Roh SY, Kim IH. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage. BMC Cancer 2019;19:1232. [PMID: 31852475 DOI: 10.1186/s12885-019-6433-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Naveed S, Qari H, Thau CM, Burasakarn P, Mir AW, Panday BB. Lymph Node Ratio is an Important Prognostic Factor in Curatively Resected Gallbladder Carcinoma, Especially in Node-positive Patients: An Experience from Endemic Region in a Developing Country. Euroasian J Hepatogastroenterol 2021;11:1-5. [PMID: 34316456 DOI: 10.5005/jp-journals-10018-1336] [Reference Citation Analysis]
26 Pedrazzani C, Sivins A, Ancans G, Marrelli D, Corso G, Krumins V, Roviello F, Leja M. Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg. 2010;34:85-91. [PMID: 20020295 DOI: 10.1007/s00268-009-0288-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
27 Yagi Y, Ii T, Tanaka S, Oguri H. Resection of distal gastric tube cancer with sentinel node biopsy: a case report and review of the literature. World J Surg Oncol. 2015;13:10. [PMID: 25627444 DOI: 10.1186/s12957-014-0421-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
28 Deng JY, Liang H, Sun D, Zhan HJ, Zhang RP. Analysis of risk factors for the interval time, number and pattern of hepatic metastases from gastric cancer after radical gastrectomy. World J Gastroenterol 2008; 14(15): 2440-2447 [PMID: 18416477 DOI: 10.3748/wjg.14.2440] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
29 Zhang M, Zhu G, Ma Y, Xue Y. Comparison of four staging systems of lymph node metastasis in gastric cancer. World J Surg. 2009;33:2383-2388. [PMID: 19760313 DOI: 10.1007/s00268-009-0214-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
30 Kunisaki C, Makino H, Akiyama H, Otsuka Y, Ono HA, Kosaka T, Takagawa R, Nagahori Y, Takahashi M, Kito F. Clinical significance of the metastatic lymph-node ratio in early gastric cancer. J Gastrointest Surg. 2008;12:542-549. [PMID: 17851724 DOI: 10.1007/s11605-007-0239-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
31 Attaallah W, Uprak K, Gunal O, Yegen C. Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer. Indian J Surg Oncol 2016;7:67-72. [PMID: 27065685 DOI: 10.1007/s13193-016-0490-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
32 Calero A, Escrig-Sos J, Mingol F, Arroyo A, Martinez-Ramos D, de Juan M, Salvador-Sanchis JL, Garcia-Granero E, Calpena R, Lacueva FJ. Usefulness of the log odds of positive lymph nodes to predict and discriminate prognosis in gastric carcinomas. J Gastrointest Surg 2015;19:813-20. [PMID: 25560183 DOI: 10.1007/s11605-014-2728-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
33 Jonnalagadda S, Smith C, Mhango G, Wisnivesky JP. The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer. Chest 2011;140:433-40. [PMID: 21292754 DOI: 10.1378/chest.10-2885] [Cited by in Crossref: 34] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
34 Kim Y, Park SH, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Lee SJ, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK. The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III Trial. J Gastric Cancer 2016;16:105-10. [PMID: 27433396 DOI: 10.5230/jgc.2016.16.2.105] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
35 Hwang JE, Kim H, Shim HJ, Bae WK, Hwang EC, Jeong O, Ryu SY, Park YK, Cho SH, Chung IJ. Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer. J Cancer Res Clin Oncol 2019;145:2157-66. [PMID: 31273512 DOI: 10.1007/s00432-019-02963-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
36 Toiyama Y, Fujikawa H, Koike Y, Saigusa S, Inoue Y, Tanaka K, Mohri Y, Miki C, Kusunoki M. Evaluation of preoperative C-reactive protein aids in predicting poor survival in patients with curative colorectal cancer with poor lymph node assessment. Oncol Lett 2013;5:1881-8. [PMID: 23833661 DOI: 10.3892/ol.2013.1308] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
37 Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, Roviello F, de Manzoni G, Minicozzi A, Natalini G, De Santis F, Baiocchi L, Coniglio A, Nitti D; Italian Research Group for Gastric Cancer (IRGGC). The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245:543-52. [PMID: 17414602 DOI: 10.1097/01.sla.0000250423.43436.e1] [Cited by in Crossref: 254] [Cited by in F6Publishing: 262] [Article Influence: 18.1] [Reference Citation Analysis]
38 Wisnivesky JP, Arciniega J, Mhango G, Mandeli J, Halm EA. Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer. Thorax 2011;66:287-93. [PMID: 21131298 DOI: 10.1136/thx.2010.148601] [Cited by in Crossref: 32] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
39 Deng J, Liang H, Sun D, Pan Y, Liu Y, Wang D. Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbecks Arch Surg. 2011;396:615-623. [PMID: 21380618 DOI: 10.1007/s00423-011-0753-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
40 Arigami T, Natsugoe S, Uenosono Y, Arima H, Mataki Y, Ehi K, Yanagida S, Ishigami S, Hokita S, Aikou T. Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer. Br J Cancer 2005;93:688-93. [PMID: 16136051 DOI: 10.1038/sj.bjc.6602739] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 4.5] [Reference Citation Analysis]
41 Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, Berger DL, Ferguson CM, Rattner DW, Yoon SS. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2010;17:1267-1277. [PMID: 20099040 DOI: 10.1245/s10434-010-0914-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
42 Huang CM, Lin BJ, Lu HS, Zhang XF, Li P, Xie JW. Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus. World J Gastroenterol 2008; 14(27): 4383-4388 [PMID: 18666330 DOI: 10.3748/wjg.14.4383] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
43 Wang H, Xing XM, Ma LN, Liu L, Hao J, Feng LX, Yu Z. Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer. Oncol Lett 2018;15:8853-62. [PMID: 29844813 DOI: 10.3892/ol.2018.8497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
44 Li J, Lin Y, Wang Y, Lin H, Lin F, Zhuang Q, Lin X, Wu J. Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis. ESMO Open 2020;5:e000632. [PMID: 32253246 DOI: 10.1136/esmoopen-2019-000632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Adsay NV, Basturk O, Altinel D, Khanani F, Coban I, Weaver DW, Kooby DA, Sarmiento JM, Staley C. The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment. Mod Pathol 2009;22:107-12. [PMID: 18820663 DOI: 10.1038/modpathol.2008.167] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
46 Cidón EU. Gastric cancer and the search for a good prognostic classification: a challenge. Clin Exp Gastroenterol 2010;3:113-6. [PMID: 21694854 DOI: 10.2147/ceg.s11929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
47 Huang Q. Carcinoma of the gastroesophageal junction in Chinese patients. World J Gastroenterol 2012; 18(48): 7134-7140 [PMID: 23326117 DOI: 10.3748/wjg.v18.i48.7134] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
48 Konstantinidis IT, Deshpande V, Zheng H, Wargo JA, Fernandez-del Castillo C, Thayer SP, Androutsopoulos V, Lauwers GY, Warshaw AL, Ferrone CR. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma? J Gastrointest Surg 2010;14:261-7. [PMID: 19937477 DOI: 10.1007/s11605-009-1096-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
49 Hong SA, Son MW, Cho J, Lee CH, Jang SH, Lee HJ, Lee JH, Cho HD, Oh MH, Lee KT, Lee MS. Prognostic value of fibrosis ratio in metastatic lymph nodes of node-positive advanced gastric cancer. Medicine (Baltimore) 2018;97:e9703. [PMID: 29505025 DOI: 10.1097/MD.0000000000009703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Sianesi M, Bezer L, Del Rio P, Dell’Abate P, Iapichino G, Soliani P, Tacci S. The node ratio as prognostic factor after curative resection for gastric cancer. J Gastrointest Surg. 2010;14:614-619. [PMID: 20101526 DOI: 10.1007/s11605-009-1142-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
51 Martin JA, Warner RRP, Aronson A, Wisnivesky JP, Kim MK. Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors. Pancreas. 2017;46:1214-1218. [PMID: 28902794 DOI: 10.1097/mpa.0000000000000921] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
52 Choi BG, Kim CY, Cho SH, Kim HJ, Koh YS, Kim JC, Cho CK, Kim HJ, Hur YH. Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma. J Korean Surg Soc. 2013;84:168-177. [PMID: 23487246 DOI: 10.4174/jkss.2013.84.3.168] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
53 Medani M, Kelly N, Samaha G, Duff G, Healy V, Mulcahy E, Condon E, Waldron D, Saunders J, Coffey JC. An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all. Int J Colorectal Dis. 2013;28:1377-1384. [PMID: 23715847 DOI: 10.1007/s00384-013-1707-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
54 Fukuda N. Moving from lymph node metastasis in gastric cancer to biological markers: reply to letter. World J Surg 2010;34:1142-3. [PMID: 20155265 DOI: 10.1007/s00268-010-0461-0] [Reference Citation Analysis]
55 Kim Y, Squires MH, Poultsides GA, Fields RC, Weber SM, Votanopoulos KI, Kooby DA, Worhunsky DJ, Jin LX, Hawkins WG, Acher AW, Cho CS, Saunders N, Levine EA, Schmidt CR, Maithel SK, Pawlik TM. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy. Surgery 2017;162:285-94. [PMID: 28578142 DOI: 10.1016/j.surg.2017.03.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
56 Natsugoe S, Arigami T, Uenosono Y, Yanagita S. Novel surgical approach based on the sentinel node concept in patients with early gastric cancer. Ann Gastroenterol Surg. 2017;1:180-185. [PMID: 29863111 DOI: 10.1002/ags3.12027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
57 Ema A, Yamashita K, Sakuramoto S, Wang G, Mieno H, Nemoto M, Shibata T, Katada N, Kikuchi S, Watanabe M. Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy. Gastric Cancer. 2014;17:67-75. [PMID: 23801337 DOI: 10.1007/s10120-013-0253-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
58 Wentz SC, Zhao ZG, Shyr Y, Shi CJ, Merchant NB, Washington K, Xia F, Chakravarthy AB. Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol 2012; 4(10): 207-215 [PMID: 23444312 DOI: 10.4251/wjgo.v4.i10.207] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
59 Partelli S, Fernandez-Del Castillo C, Bassi C, Mantovani W, Thayer SP, Crippa S, Ferrone CR, Falconi M, Pederzoli P, Warshaw AL, Salvia R. Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio. Ann Surg 2010;251:477-82. [PMID: 20142730 DOI: 10.1097/SLA.0b013e3181cf9155] [Cited by in Crossref: 54] [Cited by in F6Publishing: 21] [Article Influence: 4.9] [Reference Citation Analysis]
60 Afaneh C, Levy A, Selby L, Ku G, Tang L, Yoon SS, Coit D, Strong VE. Ex Vivo Lymphadenectomy During Gastrectomy for Adenocarcinoma Optimizes Lymph Node Yield. J Gastrointest Surg 2016;20:165-71; discussion 171. [PMID: 26403717 DOI: 10.1007/s11605-015-2948-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
61 Xiao LB, Yu JX, Wu WH, Xu FF, Yang SB. Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer. World J Gastroenterol 2011; 17(46): 5123-5130 [PMID: 22171148 DOI: 10.3748/wjg.v17.i46.5123] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]